FERNDALE, Mich. — Ferndale Healthcare recently announced a three-year partnership on behalf of its RectiCare (lidocaine 5%) Anorectal Cream brand and the Colon Cancer Alliance. This nonprofit corporation is the nation’s leading patient advocacy organization dedicated to increasing colon cancer screening rates and survivorship.
Through this partnership, RectiCare hopes to further the mission of the Colon Cancer Alliance by generating awareness and educating consumers. And over the next three years, RectiCare will be providing financial support to benefit the programs of the Colon Cancer Alliance. Plans to add the Colon Cancer Alliance logo to the RectiCare website Recticare.com, product packaging and collateral materials are currently in the works, Ferndale reported.
"Consumers experiencing such symptoms as bleeding, soreness and pain are often tempted to self-treat using a variety of over-the-counter preparations. They believe they have hemorrhoids, fissures or other very common anal-rectal maladies,” stated Katherine Gunn, product manager for RectiCare. “We believe it is … our responsibility to encourage consumers to see their physicians to rule out a serious underlying disease, such as colon cancer.”